Injectable Platelet Rich Fibrin With Collagen Matrix in Treatment of Multiple Gingival Recession.
NCT ID: NCT05389059
Last Updated: 2022-05-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2022-04-25
2023-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Recombinant Human Platelet-derived Growth Factor in Combination With Collagen Matrix
NCT04462237
Benefits of Platelet Rich Fibrin In Mandibular Molar Furcation Defects
NCT02430519
Treatment of Gingival Recession Defects Using Platelet-Rich Fibrin With an Allogenic Dermal Matrix
NCT05819515
Treatment of Local Gingival Recession With an Enamel Matrix Protein Coated Collagen Matrix
NCT05799859
The Effect of (L-PRF) Membrane in The Treatment of Gingival Recession
NCT04224935
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control arm
Patients with Gingival recessions are type 1 recession RT1 (cairo et al,2011) which correspond to Miller I\&II gingival recession.
CAF+CM
Periodontal surgery including CAF+CM application
Experimental arm
Patients with Gingival recessions are type 1 recession RT1 (cairo et al,2011) which correspond to Miller I\&II gingival recession.
CAF+CM
Periodontal surgery including CAF+CM application
I-PRF
Periodontal surgery including CAF+CM application with i-PRF
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CAF+CM
Periodontal surgery including CAF+CM application
I-PRF
Periodontal surgery including CAF+CM application with i-PRF
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The cemento-enamel junction (CEJ) is visible in the teeth for root coverage procedures.
* All recessions are type 1recession RT1 (cairo et al,2011) which correspond to Miller I\&II gingival recession
* All patients must demonstrate adequate plaque control with a fullmouth plaque score less than 20% and with .
* All patients at least 18 years of age and of both genders.
Exclusion Criteria
* Patients with diabetes.
* Patients with a history of malignancy, radiotherapy, or chemotherapy for malignancy.
* pregnant or nursing women.
* Patients taking medications or having treatments with an effect on mucosal healing in general (e.g. steroids, large doses of antiinflammatory drugs).
* Patients with a disease affecting connective tissue metabolism.
* Patients allergic to collagen.
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Baghdad
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Basima Ghaffoori Ali
PHD student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Basima Gh Ali, MSc
Role: PRINCIPAL_INVESTIGATOR
University of Baghdad
Thair AL Hassan, PHD
Role: STUDY_DIRECTOR
University of Baghdad
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Baghdad / College of Dentistry
Baghdad, , Iraq
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
519622
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.